Clinical trial
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers
NCT00136890 · Ontario Clinical Oncology Group (OCOG), Other · Completed
Key facts
| NCT number | NCT00136890 |
|---|---|
| Title | PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers |
| Official title | The Impact of Positron Emission Tomography (PET) Imaging in Staging Potentially Surgically Resectable Non-small Cell Lung Cancers: A Prospective Multicentre Randomized Clinical Trial |
| Acronym | ELPET |
| Lead sponsor | Ontario Clinical Oncology Group (OCOG), Other |
| Collaborators | Ontario Ministry of Health and Long Term Care |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-small-cell Lung Carcinoma |
| Intervention type | Procedure |
| Interventions | PET Imaging |
| Enrollment | 337 |
| Start date | Jul 1, 2004 |
| Primary completion | Nov 1, 2008 |
| Completion | Jan 1, 2013 |
| First posted | Aug 29, 2005 |
| Last update posted | Jan 15, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: